Fiche centre
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu
Wroclaw — Poland
Essais liés4clinical trials
VilleWroclawlocalisation
PaysPolandlocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07188805
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Bimagrumab | Maladie coronarienne | Phase 2 | NCT07920887 | ACTIVATE-HFpEF — A Study of Bimagrumab in Participants With HFpEF | NOT_YET_RECRUITING |
| Finerenone (Kerendia, BAY94-8862) | Insuffisance cardiaque | Phase 3 | NCT07192952 | FIORELLO — A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction | RECRUITING |
| Finerenone (Kerendia, BAY94-8862) | Insuffisance cardiaque | Phase 3 | NCT07188805 | FIORE — A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction | RECRUITING |
| Obinutuzumab | Lupus | Phase 3 | NCT04221477 | REGENCY — A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis | ACTIVE_NOT_RECRUITING |